- Home
- OTLK vs TOP Comparison
OTLK vs TOP Comparison
Compare OTLK & TOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- TOP
- Stock Information
- Founded
- OTLK 2010
- TOP 2015
- Country
- OTLK United States
- TOP Singapore
- Employees
- OTLK N/A
- TOP N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- TOP Investment Bankers/Brokers/Service
- Sector
- OTLK Health Care
- TOP Finance
- Exchange
- OTLK Nasdaq
- TOP Nasdaq
- Market Cap
- OTLK 48.3M
- TOP 42.5M
- IPO Year
- OTLK 2016
- TOP 2022
- Fundamental
- Price
- OTLK $2.34
- TOP $1.18
- Analyst Decision
- OTLK Strong Buy
- TOP
- Analyst Count
- OTLK 5
- TOP 0
- Target Price
- OTLK $9.60
- TOP N/A
- AVG Volume (30 Days)
- OTLK 1.1M
- TOP 32.8K
- Earning Date
- OTLK 08-14-2025
- TOP 08-13-2025
- Dividend Yield
- OTLK N/A
- TOP N/A
- EPS Growth
- OTLK N/A
- TOP N/A
- EPS
- OTLK N/A
- TOP N/A
- Revenue
- OTLK $1,505,322.00
- TOP $3,329,256.00
- Revenue This Year
- OTLK N/A
- TOP N/A
- Revenue Next Year
- OTLK $407.74
- TOP N/A
- P/E Ratio
- OTLK N/A
- TOP N/A
- Revenue Growth
- OTLK N/A
- TOP N/A
- 52 Week Low
- OTLK $0.87
- TOP $1.00
- 52 Week High
- OTLK $8.32
- TOP $1.94
- Technical
- Relative Strength Index (RSI)
- OTLK 63.83
- TOP 50.08
- Support Level
- OTLK $1.95
- TOP $1.10
- Resistance Level
- OTLK $2.14
- TOP $1.20
- Average True Range (ATR)
- OTLK 0.17
- TOP 0.05
- MACD
- OTLK 0.03
- TOP 0.00
- Stochastic Oscillator
- OTLK 77.62
- TOP 84.62
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.